Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    NCT00440050

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: DHA (Docosahexaenoic Acid);   Drug: Placebo
To Top

† Indicates status has not been verified in more than two years